ACTO Named a Luminary in Everest Group's "Innovation Watch: Agentic AI in Life Sciences Commercial 2026"

Positive

AI Analysis

Summary

ACTO has been recognized as a Luminary in Everest Group's 2026 Innovation Watch report for its role-based SuperAgents and agentic AI solutions in Life Sciences. The recognition highlights ACTO's approach to governed agentic AI with cross-platform orchestration capabilities.

Importance:2/10

Sentiment:

0.60

AILife SciencesRecognitionCommercialAgentic AI

Related Companies

$CCRN

Read the original article

Published by PR Newswire Biotech on October 5, 2026 12:30 PM

Read Original